Richard N. Yu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sperm Retrieval | 3 | 2023 | 23 | 1.070 |
Why?
|
| Sex Reassignment Surgery | 3 | 2024 | 164 | 1.010 |
Why?
|
| Vesico-Ureteral Reflux | 7 | 2016 | 433 | 0.830 |
Why?
|
| Disorders of Sex Development | 3 | 2024 | 129 | 0.800 |
Why?
|
| Sexual Development | 2 | 2021 | 39 | 0.750 |
Why?
|
| Infertility, Male | 3 | 2019 | 395 | 0.740 |
Why?
|
| Semen Preservation | 1 | 2019 | 35 | 0.660 |
Why?
|
| Cryopreservation | 3 | 2021 | 727 | 0.610 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2023 | 1142 | 0.550 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2016 | 163 | 0.520 |
Why?
|
| Health Facilities | 1 | 2020 | 578 | 0.490 |
Why?
|
| Penis | 1 | 2016 | 209 | 0.490 |
Why?
|
| Urologic Diseases | 3 | 2018 | 246 | 0.480 |
Why?
|
| Dextrans | 2 | 2006 | 573 | 0.460 |
Why?
|
| Resuscitation Orders | 1 | 2016 | 271 | 0.450 |
Why?
|
| Hyaluronic Acid | 2 | 2006 | 484 | 0.420 |
Why?
|
| Bupivacaine | 1 | 2016 | 414 | 0.420 |
Why?
|
| Sperm Banks | 1 | 2012 | 7 | 0.410 |
Why?
|
| Nephrectomy | 1 | 2016 | 928 | 0.370 |
Why?
|
| Ureter | 4 | 2016 | 364 | 0.360 |
Why?
|
| Semen Analysis | 1 | 2012 | 235 | 0.340 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 1005 | 0.330 |
Why?
|
| Nerve Block | 1 | 2016 | 717 | 0.330 |
Why?
|
| Laparoscopy | 2 | 2017 | 2039 | 0.300 |
Why?
|
| Replantation | 2 | 2016 | 145 | 0.240 |
Why?
|
| Ureteroscopy | 1 | 2006 | 139 | 0.240 |
Why?
|
| Klinefelter Syndrome | 2 | 2015 | 48 | 0.230 |
Why?
|
| Seminal Vesicles | 1 | 2024 | 101 | 0.230 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2730 | 0.220 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2018 | 364 | 0.220 |
Why?
|
| Microspheres | 1 | 2006 | 774 | 0.220 |
Why?
|
| Colpotomy | 1 | 2022 | 9 | 0.200 |
Why?
|
| Urogenital Abnormalities | 2 | 2017 | 255 | 0.200 |
Why?
|
| Survivors | 1 | 2012 | 2379 | 0.190 |
Why?
|
| Acetates | 1 | 2023 | 314 | 0.190 |
Why?
|
| Varicocele | 1 | 2021 | 75 | 0.190 |
Why?
|
| Testis | 2 | 2023 | 784 | 0.180 |
Why?
|
| Cryptorchidism | 1 | 2021 | 152 | 0.180 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2021 | 94 | 0.180 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2023 | 731 | 0.180 |
Why?
|
| Spermatozoa | 2 | 2023 | 626 | 0.170 |
Why?
|
| DNA | 1 | 2014 | 7205 | 0.170 |
Why?
|
| Turner Syndrome | 1 | 2021 | 129 | 0.170 |
Why?
|
| Semen | 1 | 2023 | 349 | 0.170 |
Why?
|
| Hypogonadism | 2 | 2017 | 802 | 0.170 |
Why?
|
| Adolescent | 19 | 2024 | 88877 | 0.160 |
Why?
|
| Urinary Tract | 2 | 2013 | 305 | 0.160 |
Why?
|
| Testosterone | 2 | 2023 | 2495 | 0.150 |
Why?
|
| Urethral Stricture | 1 | 2017 | 50 | 0.150 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2017 | 79 | 0.140 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 195 | 0.140 |
Why?
|
| Stem Cells | 1 | 2009 | 3538 | 0.140 |
Why?
|
| Endoscopy | 1 | 2006 | 1854 | 0.130 |
Why?
|
| Urology | 2 | 2012 | 384 | 0.130 |
Why?
|
| Catheters, Indwelling | 1 | 2018 | 436 | 0.130 |
Why?
|
| Child | 18 | 2024 | 80653 | 0.120 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 805 | 0.120 |
Why?
|
| Gels | 2 | 2006 | 420 | 0.120 |
Why?
|
| Male | 29 | 2024 | 363931 | 0.120 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 12803 | 0.120 |
Why?
|
| Prostate | 1 | 2022 | 1757 | 0.110 |
Why?
|
| Infant | 7 | 2024 | 36458 | 0.110 |
Why?
|
| Contraceptive Agents, Male | 1 | 2012 | 8 | 0.100 |
Why?
|
| Humans | 34 | 2024 | 766351 | 0.100 |
Why?
|
| Neoplasms | 2 | 2019 | 22343 | 0.090 |
Why?
|
| Clinical Competence | 2 | 2017 | 4858 | 0.090 |
Why?
|
| Child, Preschool | 9 | 2024 | 42568 | 0.090 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 1667 | 0.090 |
Why?
|
| Functional Laterality | 1 | 2017 | 2243 | 0.090 |
Why?
|
| Azepines | 1 | 2012 | 329 | 0.090 |
Why?
|
| GATA6 Transcription Factor | 1 | 2010 | 54 | 0.090 |
Why?
|
| GATA4 Transcription Factor | 1 | 2010 | 125 | 0.080 |
Why?
|
| Retrospective Studies | 11 | 2024 | 81577 | 0.080 |
Why?
|
| Consensus | 1 | 2019 | 3198 | 0.080 |
Why?
|
| Hormone Replacement Therapy | 1 | 2015 | 751 | 0.080 |
Why?
|
| Young Adult | 10 | 2022 | 59906 | 0.080 |
Why?
|
| Multipotent Stem Cells | 1 | 2009 | 200 | 0.080 |
Why?
|
| Urothelium | 1 | 2010 | 275 | 0.080 |
Why?
|
| Germ Cells | 1 | 2011 | 646 | 0.070 |
Why?
|
| Tretinoin | 1 | 2010 | 524 | 0.070 |
Why?
|
| Triazoles | 1 | 2012 | 902 | 0.070 |
Why?
|
| Urinary Tract Infections | 1 | 2013 | 804 | 0.070 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 1769 | 0.060 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 280 | 0.060 |
Why?
|
| Physician's Role | 1 | 2012 | 925 | 0.060 |
Why?
|
| Therapeutic Irrigation | 1 | 2006 | 293 | 0.060 |
Why?
|
| Pediatrics | 2 | 2017 | 3613 | 0.060 |
Why?
|
| Wolffian Ducts | 1 | 2024 | 27 | 0.060 |
Why?
|
| Urologic Surgical Procedures | 2 | 2017 | 281 | 0.060 |
Why?
|
| Forecasting | 2 | 2010 | 2935 | 0.060 |
Why?
|
| Injections | 1 | 2006 | 839 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1243 | 0.050 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 808 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5753 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2016 | 15818 | 0.050 |
Why?
|
| Orchiopexy | 1 | 2021 | 21 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1600 | 0.050 |
Why?
|
| Metaplasia | 1 | 2022 | 326 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2012 | 2518 | 0.040 |
Why?
|
| Female | 17 | 2024 | 396307 | 0.040 |
Why?
|
| Hospitals, Pediatric | 2 | 2021 | 1851 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 3607 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 2505 | 0.040 |
Why?
|
| Orchiectomy | 1 | 2021 | 465 | 0.040 |
Why?
|
| Cysts | 1 | 2024 | 685 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5367 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 2306 | 0.040 |
Why?
|
| Urogenital System | 1 | 2018 | 88 | 0.040 |
Why?
|
| Syndrome | 1 | 2024 | 3271 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7426 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 5794 | 0.040 |
Why?
|
| Internet | 1 | 2010 | 3111 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2012 | 4278 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2024 | 1424 | 0.030 |
Why?
|
| Boston | 2 | 2021 | 9333 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2021 | 65201 | 0.030 |
Why?
|
| Urination | 1 | 2017 | 204 | 0.030 |
Why?
|
| Circumcision, Male | 1 | 2017 | 150 | 0.030 |
Why?
|
| Vagina | 1 | 2022 | 849 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 13472 | 0.030 |
Why?
|
| Physical Examination | 1 | 2021 | 1265 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9521 | 0.030 |
Why?
|
| Radiography | 1 | 2006 | 6967 | 0.030 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2017 | 287 | 0.030 |
Why?
|
| Androgens | 1 | 2022 | 1279 | 0.030 |
Why?
|
| Adult | 7 | 2022 | 223220 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2009 | 3458 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2021 | 1635 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2018 | 943 | 0.030 |
Why?
|
| Recurrence | 1 | 2006 | 8478 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2017 | 771 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2006 | 5988 | 0.030 |
Why?
|
| Blood-Testis Barrier | 1 | 2012 | 12 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 368 | 0.020 |
Why?
|
| Sperm Count | 1 | 2012 | 227 | 0.020 |
Why?
|
| Psychophysiologic Disorders | 1 | 2013 | 222 | 0.020 |
Why?
|
| Karyotyping | 1 | 2013 | 1176 | 0.020 |
Why?
|
| Sperm Motility | 1 | 2012 | 264 | 0.020 |
Why?
|
| Urinary Bladder Diseases | 1 | 2012 | 166 | 0.020 |
Why?
|
| Somatomedins | 1 | 2011 | 179 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2011 | 126 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2108 | 0.020 |
Why?
|
| Endocrinology | 1 | 2017 | 441 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 40112 | 0.020 |
Why?
|
| Equipment Design | 1 | 2018 | 3481 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 294 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 220 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 2010 | 384 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2012 | 992 | 0.020 |
Why?
|
| Counseling | 1 | 2017 | 1552 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1186 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2013 | 2272 | 0.020 |
Why?
|
| Living Donors | 1 | 2012 | 647 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2973 | 0.020 |
Why?
|
| Age Distribution | 1 | 2013 | 2868 | 0.020 |
Why?
|
| Ecosystem | 1 | 2011 | 489 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1562 | 0.020 |
Why?
|
| Animals | 4 | 2012 | 168887 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3757 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3616 | 0.020 |
Why?
|
| Contrast Media | 1 | 2018 | 5326 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6212 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2021 | 54809 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 4860 | 0.010 |
Why?
|
| Curriculum | 1 | 2017 | 3783 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 22337 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7840 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2012 | 5385 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8719 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39269 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2012 | 2101 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 8060 | 0.010 |
Why?
|
| Prognosis | 2 | 2012 | 29921 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 30229 | 0.010 |
Why?
|
| Zebrafish | 1 | 2011 | 3035 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2010 | 5890 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12060 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 18395 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 3702 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5197 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5789 | 0.010 |
Why?
|
| Comorbidity | 1 | 2013 | 10579 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13274 | 0.010 |
Why?
|
| United States | 2 | 2016 | 72909 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 3719 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 12978 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11059 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15390 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 12788 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2010 | 5086 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15897 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 21506 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 18979 | 0.010 |
Why?
|
| Mice | 2 | 2012 | 81863 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 16718 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2010 | 7866 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 24272 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 41698 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 23611 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 74825 | 0.000 |
Why?
|
| Aged | 1 | 2017 | 171208 | 0.000 |
Why?
|
| Middle Aged | 1 | 2017 | 223092 | 0.000 |
Why?
|